Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Pfizer Ventures is the corporate venture capital arm of Pfizer that invests in transformative therapeutics and platform technologies across oncology, inflammation, immunology, cardiovascular, metabolic/obesity, and vaccines. It provides strategic guidance, capital, and access to Pfizer's expertise to portfolio companies from seed through IPO, with typical initial investments of $5–20 million.
Parse Score